The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders

Ryan A Bragg1, Nick Bushby2, Cecilia Ericsson3

  • 1Drug Safety & Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Cambridgeshire, UK. ryan.bragg@astrazeneca.com.